SLN: Silence Therapeutics Corp Narx-foyda va o‘sish multiplikatori
Silence Therapeutics (SLN) kompaniyasining istiqbollari yurak-qon tomir patologiyalarini davolashda uning siRNA platformasining muvaffaqiyati va yirik hamkorlardan tushadigan to'lovlar bilan belgilanadi. P/E koeffitsiyentining o'sish tendentsiyasi foydaga nisbatan bozor bahosini aks ettiradi, bunda 0.00 joriy ko'rsatkichni ifodalaydi. RNA interferentsiyasidagi yetakchilik va zerlasiranning salohiyati o'sish katalizatorlarini yaratadi, ammo shaxsiy chakana savdo daromadlarining yo'qligi biznesni tashqi moliyalashtirishga bog'liq qiladi.
Silence Therapeutics (SLN) kompaniyasining tahliliy kesimlari
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Jamlagan qarzning kapitalga nisbati Silence Therapeutics|SLN - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati silence-therapeutics.com|SLN - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Silence Therapeutics Inc.|SLN - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari Silence Therapeutics|Tezkor likvidlik koeffitsiyenti silence-therapeutics.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
SLN - Kompaniyaning sof foydasi|Forvard foyda Silence Therapeutics|SLN - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Silence Therapeutics Corp|SLN - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori Silence Therapeutics Inc.|SLN - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda Silence Therapeutics|SLN - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi silence-therapeutics.com|SLN - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Silence Therapeutics
Kompaniyaning umumiy tahlili:SLN - Silence Therapeutics PLC
Jigarga yetkazib beruvchi siRNA platformasi uchun patentlarga ega bo'lgan Silence Therapeutics (SLN) biotexnologiya kompaniyasi uchun PEG koeffitsiyenti foydaning bozor qiymatini ularning o'sish sur'ati bilan solishtiradi. PEG omili orqali biznesning past baholanganligini tahlil qilib, investor noyob kasalliklarni davolashdagi kengayish sur'ati joriy multiplikatorni oqlash-oklamasligini aniqlaydi, bunda birdan past qiymat aktivning fundamental o'sish salohiyatidan dalolat beradi.
Silence Therapeutics raqobatchilari
Tempus AI, Inc - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori QGEN (Qiagen Group)|IONS - Narx-foyda va o‘sish multiplikatori|Repligen Corporation - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda aviditybiosciences.com|CRSP (CRISPR Therapeutics) - Narx-foyda va o‘sish multiplikatori|GeneDx Holdings - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori RARE|BEAM (Beam Tx) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori SRPT|TWST (twistbioscience.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori TXG (10x Genomics)|Intellia Therapeutics Inc (NTLA) - O‘sish sur’atiga tuzatilgan narx-foyda|STOK - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti BLFS (BioLife)|WVE: PEG multiplikatori|mazetx.com (MAZE) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Sionna Therapeutics|Prime Medicine Inc - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori TSHA|QURE - O‘sish sur’atiga tuzatilgan narx-foyda|MeiraGTx Holdings plc - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori regenxbio.com RGNX|SLDB: Narx-foyda va o‘sish multiplikatori|Ocugen Inc - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PACB: PEG multiplikatori|BNTC - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|DSGN (Design Therapeutics) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori rocketpharma.com (RCKT)|Narxning foydaga va o‘sish sur’atiga nisbati 4D Molecular Therapeutics, Inc. (FDMT)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati lexeotx.com|Narxning foydaga va o‘sish sur’atiga nisbati Korro Bio KRRO|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Editas Corp (EDIT)|PRQR - Narxning foydaga va o‘sish sur’atiga nisbati|CDXS: Narxning foydaga va o‘sish sur’atiga nisbati|Sangamo Therapeutics, Inc. (SGMO) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti NAUT|MGX (Metagenomi, Inc) - PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti DTIL (Precision BioSciences Inc.)|Narxning foydaga va o‘sish sur’atiga nisbati Generation Bio Co. (GBIO)|boundlessbio.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori XCUR (Exicure)|PEG multiplikatori Imunon Inc IMNN|PHIO - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Mustang Bio, Inc. MBIO|RNAZ: PEG multiplikatori|BNGO - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Applied DNA Sciences, Inc.|Narxning foydaga va o‘sish sur’atiga nisbati BLUE|PEG multiplikatori IPA|OMGA - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Singular Genomics Systems OMIC|RGLS: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Syros Pharmaceuticals, Inc. - PEG multiplikatori|Telesis Bio Inc. (TBIO) - Narx-foyda va o‘sish multiplikatori|TCON: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Unity Biotechnology, Inc (UBX)
